About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Potential Alternative Drug Therapies for Neuroblastoma Uncovered

by Bidita Debnath on May 27, 2013 at 10:06 PM
Font : A-A+

 Potential Alternative Drug Therapies for Neuroblastoma Uncovered

Nearly two-thirds of patients with high-risk neuroblastoma cannot be cured using tumor-killing cancer drugs. Neuroblastoma is a common tumor that forms in the nerve cells of children.

A study published by Cell Press in the May 23 issue of Chemistry & Biology reveals a new genomic approach to screen for compounds that could inhibit tumor growth by causing cancer cells to differentiate, or convert from immature cells to more specialized cell types. Using this screening method, the researchers identified a compound that causes neuroblastoma cells to differentiate, uncovering a promising new treatment strategy for this highly malignant pediatric cancer.

Advertisement

"New treatment approaches are very much needed for children with high-risk childhood cancers; that is, those that are metastatic at diagnosis and likely to recur," says senior study author Kimberly Stegmaier of the Dana-Farber/Children's Hospital Cancer Center and the Broad Institute of the Massachusetts Institute of Technology and Harvard University. "By focusing on an alternative strategy to treating neuroblastoma tumors, we identified a compound class that in early testing in neuroblastoma cells in the laboratory shows promise for treating children with this disease."

Beyond the standard approach of using drugs that kill tumor cells, another promising strategy is to identify compounds that promote differentiation, which causes tumor cells to stop dividing and growing. But the benefits of differentiation therapy had not been fully explored.
Advertisement

To address this need, Stegmaier and her team developed a method to screen small molecules for their ability to trigger differentiation in neuroblastoma cells. First, they treated these cells with drugs known to induce differentiation and looked for accompanying changes in the activity levels of genes. They found that 59 genes showed changes related to differentiation. Using this genetic signature for differentiation, they then screened nearly 2,000 small molecules and identified one compound that strongly promoted differentiation in neuroblastoma cells, especially when combined with a drug already approved to treat this type of cancer.

The newly identified compound works by selectively inhibiting a subset of gene-regulating proteins called histone deacetylases (HDACs). "This work supports the need to develop selective HDAC inhibitors for clinical application and, more broadly, illuminates the power of integrating signature-based screening with new approaches to chemical synthesis to provide novel biological insights into human disease," Stegmaier says.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Signature Drug Toxicity Neuroblastoma 

Recommended Reading
Stem Cell Therapy Used in US for Treating Neuroblastoma in Children More Toxic Than European or Egyptian Regimens
A new study suggests that the current stem cell transplant regimen to treat advanced neuroblastoma ....
Neuroblastomas Vulnerable to a New Class of Anti-Cancer Drugs
The efficacy of new anti-cancer drugs known as BET bromodomain inhibitors may be undertood by an ......
Biomarker may Identify Neuroblastomas With Sensitivity to BET Bromodomain Inhibitors: Researchers
Neuroblastoma is the most common malignant tumor of early childhood. It is frequently associated ......
Whole-genome Scan Helps To Choose Best Treatment For Neuroblastoma
Doctors can now choose the best treatment option for neuroblastoma, one of the common types of ......
Drug Toxicity
Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a d...
Neuroblastoma
Neuroblastoma is a very rare type of childhood cancer that develops in immature nerve cells [neurobl...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use